Iterum Therapeutics plc Business Finance Contracts & Agreements
44 Contracts & Agreements
- Indenture Agreements (2 contracts)
- Investor Rights Agreements (2)
- Loan Agreements (4)
- Note Agreements (1)
- Purchase Agreements (10)
- Security Agreements (1)
- Share Agreements (4)
- Underwriting Agreements (2)
- Warrant Agreements (18)
- Promissory Note dated October 28, 2024 from Iterum Therapeutics International Limited to Pfizer Inc (Filed With SEC on November 1, 2024)
- Form of 5-Year Warrant Agent Agreement, by and between Iterum Therapeutics plc and Computershare Trust Company, N.A (Filed With SEC on July 17, 2024)
- Form of 1-Year Warrant Agent Agreement, by and between Iterum Therapeutics plc and Computershare Trust Company, N.A (Filed With SEC on July 17, 2024)
- Form of 5-Year Warrant to Subscribe for Ordinary Shares offered by this Prospectus (Filed With SEC on July 17, 2024)
- Form of 1-Year Warrant to Subscribe for Ordinary Shares offered by this Prospectus (Filed With SEC on July 17, 2024)
- Share Option Cancellation Agreement, dated July 7, 2022, between Iterum Therapeutics plc and Judith M. Matthews (Filed With SEC on August 12, 2022)
- Share Option Cancellation Agreement, dated July 7, 2022, between Iterum Therapeutics plc and Corey N. Fishman (Filed With SEC on August 12, 2022)
- Share Award Letter dated February 17, 2021 issued by Iterum Therapeutics plc to Dr. Michael Dunne and accepted by Dr. Michael Dunne on February 21, 2021 (Filed With SEC on May 14, 2021)
- Securities Purchase Agreement, dated as of February 9, 2021, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on March 12, 2021)
- Form of Securities Purchase Agreement, dated February 9, 2021, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on February 11, 2021)
- Form of Placement Agent Warrant (Filed With SEC on February 11, 2021)
- Form of Underwriter Warrant (Filed With SEC on February 5, 2021)
- Amended and Restated Underwriting Agreement, dated February 3, 2021 (Filed With SEC on February 5, 2021)
- Securities Purchase Agreement, dated as of October 22, 2020, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on November 16, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on October 27, 2020)
- Form of Placement Agent Warrant (Filed With SEC on October 27, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on October 27, 2020)
- Form of Warrant (Filed With SEC on October 27, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on October 21, 2020)
- Form of Placement Agent Warrant (Filed With SEC on October 21, 2020)
- Form of Pre-Funded Warrant (Filed With SEC on October 21, 2020)
- Form of Warrant (Filed With SEC on October 21, 2020)
- Securities Purchase Agreement, dated as of June 30, 2020, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on August 6, 2020)
- Securities Purchase Agreement, dated as of June 3, 2020, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on August 6, 2020)
- Form of Securities Purchase Agreement, dated June 30, 2020, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on July 1, 2020)
- Form of Placement Agent Warrant (Filed With SEC on July 1, 2020)
- Form of Warrant (Filed With SEC on July 1, 2020)
- Form of Securities Purchase Agreement, dated June 3, 2020, by and among Iterum Therapeutics plc and the purchasers party thereto (Filed With SEC on June 4, 2020)
- Form of Placement Agent Warrant (Filed With SEC on June 4, 2020)
- Form of Warrant (Filed With SEC on June 4, 2020)
- Form of Indenture (including form of note), to be dated as of the Closing Date, by and among Iterum Therapeutics Bermuda Limited, Iterum Therapeutics plc, Iterum Therapeutics... (Filed With SEC on January 17, 2020)
- Form of Indenture (including form of note), to be dated as of the Closing Date, by and among Iterum Therapeutics Bermuda Limited, Iterum Therapeutics plc, Iterum Therapeutics... (Filed With SEC on January 17, 2020)
- First Amendment to Loan and Security Agreement, dated as of January 16, 2020, by and among Iterum Therapeutics Bermuda Limited, Iterum Therapeutics International Limited, Iterum... (Filed With SEC on January 17, 2020)
- Form of Investor Rights Agreement, to be dated as of the Closing Date, by and among Iterum Therapeutics Bermuda Limited, Iterum Therapeutics plc, Iterum Therapeutics International... (Filed With SEC on January 17, 2020)
- Securities Purchase Agreement, dated as of January 16, 2020, by and among Iterum Therapeutics Bermuda Limited, Iterum Therapeutics plc, Iterum Therapeutics International Limited,... (Filed With SEC on January 17, 2020)
- Additional Form of Warrant to Subscribe for Ordinary Shares as may be issued to Life Sciences Fund II LLC pursuant to the Loan and Security Agreement (Filed With SEC on May 4, 2018)
- Additional Form of Warrant to Subscribe for Ordinary Shares as may be issued to Silicon Valley Bank pursuant to the Loan and Security Agreement (Filed With SEC on May 4, 2018)
- Warrant to Subscribe for Shares, issued to Life Sciences Fund II LLC, dated April 27, 2018 (Filed With SEC on May 4, 2018)
- Warrant to Subscribe for Shares, issued to Silicon Valley Bank, dated April 27, 2018 (Filed With SEC on May 4, 2018)
- Intellectual Property Security Agreement by and among Silicon Valley Bank, the Registrant, Iterum Therapeutics International Limited, Iterum Therapeutics US Holding Limited, and... (Filed With SEC on May 4, 2018)
